PubMed Health⌕ Search

Biomedical subjects

B Bonavida

Publications and source records attributed to B Bonavida.

At least 163 records · Page 9Linked to original sources
PubMed1984

Mechanism of cell-mediated cytotoxicity at the single cell level. VIII. Kinetics of lysis of target cells bound by more than one cytotoxic T lymphocyte.

We measured the effects of having multiple cytotoxic T lymphocytes (CTL) bound to one target cell by using the single-cell cytotoxicity in agarose assay. We found that even though there is variability in the time at which individual target cells are lysed, we can identify a general trend: the mean rate of lysis increases with the number of CTL bound per target cell, reaching a maximum when the CTL-target cell ratio is three. Combining a quantitative model for the rate of lethal hitting in multicellular conjugates with a multi-event model for the rate of target cell disintegration, we developed a new multistage kinetic model for predicting the rate of target cell lysis in multiple lymphocyte-target cell conjugates. The variability in the time at which target cells are hit and the variability in the time until they disintegrate are incorporated into the model. By analyzing our measured data in the context of the multistage kinetic model, we were able to estimate via nonlinear least squares regression the target cell disintegration rate, but not the lethal hitting rate. Lethal hitting appeared to be too fast, when compared with disintegration, to significantly affect the time of target cell lysis. By using previously determined values of the lethal hitting rate for single lymphocyte-target cell conjugates and by postulating that lymphocytes act independently of each other in delivering lethal hits, we were able to estimate the rate at which target cells are hit in multiple-lymphocyte single target cell conjugates. By using this estimate of the lethal hitting rate and the regression estimate of the disintegration rate, the multistage kinetic model gave a quantitative fit to our data. From this analysis, we found that the rate at which a target cell disintegrates after being lethally hit increases with the number of CTL per conjugate. This result is quite surprising, because once the first hit has been received, a target cell can disintegrate in a killer cell-independent manner. Under the conditions of our experiment, it appears as if target cell disintegration is not killer cell-independent. Furthermore, our analysis of the time course of target cell disintegration suggests that the process is not governed by simple first order kinetics, but rather by a more complex multistep mechanism.

Animals↗
PubMed1983

Enzyme-linked immunosorbent assay for HLA determination on fresh and dried lymphocytes.

HLA-A and -B antigens were detected on fresh and dried peripheral blood lymphocytes by an enzyme-linked immunosorbent assay. Intact cells fixed to plates with glutaraldehyde were used as antigen and anti-HLA alloantisera as a source of antibodies. Determination of HLA antigens by the ELISA technique was comparable with the complement-dependent cytotoxicity test. The relative stability of HLA antigens as shown in this report and the extensive polymorphism of the HLA system make the ELISA technique a promising tool for the analysis of HLA antigens on non-living cells including, for example, medicolegal investigation of blood stains.

Dose-Response Relationship, Immunologic↗
PubMed1983

Studies on the induction and expression of T-cell-mediated immunity. XIII. Membrane-associated antigens of cytotoxic T lymphocytes involved in cytotoxicity.

An xenogeneic rat anti-mouse T-cell serum, designated RAT*, has been shown to block the cytolytic activity of cytotoxic T lymphocytes (CTL) at a postbinding step. RAT* serum or the IgG fraction was extensively absorbed with the target cell, P815, a DBA mastocytoma, and used with or without further absorption to immunoprecipitate specific molecules from radiolabeled membrane extracts of CTL derived from either in vivo-allosensitized mice or from cytotoxic clones maintained in in vitro cultures. Cell surface sialic acid residues were labeled by oxidation with sodium periodate (NaIO4) and reduction with tritiated sodium borohydride ([3H]NaBH4). Alternatively, cell surface proteins were labeled with 125I by lactoperoxidase-catalyzed iodination. Nonidet P-40 (NP-40)-solubilized radiolabeled membranes were then immunoprecipitated with RAT* serum and analyzed by sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE). Three membrane-associated molecules of 95,000, 140,000 and 180,000 Mr were found by such analysis. The sensitivity of these three molecules to trypsinization and their susceptibility to labeling with [3H]NaBH4 suggested that they are glycoproteins. Moreover, when RAT* serum or the IgG fraction was absorbed with various cell types, its ability to immunoprecipitate the three molecules correlated with its ability to block cytolysis. Adsorption of RAT* serum with CTL, but not with nonimmune thymocytes, significantly reduced the ability of RAT* serum to inhibit cytotoxicity and to immunoprecipitate the 95k, 140k, and 180k molecules. Thus, these findings suggest that one or more of these cell surface molecules of CTL may be involved in the cytolytic process.

Animals↗
PubMed1983

Characterization of antibody-mediated inhibition of natural killer (NK) cytotoxicity: evidence for blocking of both recognition and lethal hit stages of cytolysis.

Rat antisera prepared against murine, periodate-activated alloimmune cytotoxic lymphocytes (termed RAT) have previously been shown to effectively block T-cell-mediated cytotoxicity (CMC) at the "lethal hit" stage of cytolysis (J.C. Hiserodt and B. Bonavida, J. Immunol. 126, 256, 1981). Both natural killer (NK) and cytotoxic T lymphocytes (CTL) have been shown to mediate lysis by the same pathway, namely binding of effector to target cells, programming for lysis, and killer cell-independent target cell lysis. This result suggested that the molecular mechanism of NKCMC and CTLCMC may also be similar. In this context, RAT-mediated blocking of CTL was examined for its ability to block NKCMC. The results show that (1) addition of RAT serum or IgG fractions blocked NKCMC in the absence of complement in a 4-hr 51CR-release assay, and blocking was directed at the effector cell; (2) at the single-cell level, RAT serum blocked the formation of conjugates between effector and target cells; (3) in a Ca2+-pulse experiment, in which the effectors and targets were first allowed to bind in the absence of Ca2+ for 1 hr at 37 degrees C, followed by the addition of Ca2+ to initiate the lytic event, RAT was capable of blocking cytotoxicity after conjugate formation at the Ca2+-dependent lethal hit stage of cytolysis. The similarity of results in RAT blocking experiments of both the CTL and NK systems suggests a common molecular mechanism of cytolysis.

Animals↗
PubMed1983

YAC-1 variant clones selected for resistance to natural killer cytotoxic factors are also resistant to natural killer cell-mediated cytotoxicity.

The possible involvement of natural killer cytotoxic factors (NKCF) in the lytic mechanism of natural killer (NK) cell-mediated cytotoxicity (CMC) was investigated by studying the mechanism of NK resistance of variant clones of the YAC-1 cell line. The NK-resistant YAC-1 (YAC-R) clones were generated by prolonged culture of the initially NK-sensitive YAC-1 cell line in the presence of NKCF. The YAC-R clones were resistant to lysis by NKCF as well as lysis by NK cells in a CMC assay. The defect was specific for NK CMC because the YAC-R clones could still be lysed by alloimmune cytotoxic T lymphocytes. Experiments to determine the mechanism of NK resistance of the YAC-R clones indicated that they still possessed the NK recognition structures because they formed a normal number of conjugates with murine spleen cells. In addition, the YAC-R clones, like the parental YAC-1 cell line, were able to stimulate the release of NKCF during co-culture with spleen cells. However, the YAC-R clones, in contrast to YAC-1 cells, were unable to adsorb NKCF from cell-free supernatants of such cultures. Thus, it appears that the YAC-R clones are NK resistant due to a deficiency of NKCF binding sites. The present studies demonstrate that a NK-sensitive target cell must not only be recognized by the NK cell and stimulate release of NKCF but it must also bind NKCF for cell lysis to ultimately result. These findings support our model for the mechanism of NK CMC in which it is proposed that target cell lysis is mediated by NKCF released from the effector cell.

Animals↗
PubMed1983

Studies on the mechanism of natural killer cytotoxicity. III. Activation of NK cells by interferon augments the lytic activity of released natural killer cytotoxic factors (NKCF).

The mechanism by which interferon (IFN) pretreatment of effector cells augments natural killer (NK) cell-mediated cytotoxicity (CMC) was examined by determining whether IFN has any effect on the production of natural killer cytotoxic factors (NKCF). NKCF are released into the supernatant of co-cultures of murine spleen cells and YAC-1 stimulator cells, and their lytic activity is measured against YAC-1 target cells. It was demonstrated that pretreatment of effector cells with murine fibroblast IFN or polyinosinic-polycytidylic acid (pIC) resulted in the release of NKCF with augmented lytic activity. Evidence indicated that the IFN-induced augmentation of NKCF activity required protein synthesis during the IFN pretreatment period, because concurrent pretreatment with both IFN and cycloheximide abrogated the IFN effect. Protein synthesis, however, is not required for the production of base levels of NKCF because emetine pretreatment of normal spleen cells did not result in a decrease in NKCF production. Furthermore, substantial levels of NKCF activity could be detected in freeze-thaw lysates of freshly isolated spleen cells. Cell populations enriched for NK effector cells, such as nylon wool-nonadherent nude mouse spleen cells, produced lysates with high levels of NKCF activity, whereas lysates of CBA thymocytes were devoid of NKCF activity. Pretreatment of spleen cells with either IFN or pIC resulted in an augmentation of the NKCF activity present in their cell lysates. Taken altogether, these findings suggest that freshly isolated NK cells contain preformed pools of NKCF. Pretreatment of these cells with IFN causes de novo synthesis of additional NKCF and/or activation of preexisting NKCF. According to our model for the mechanism of NK CMC, target cell lysis is ultimately the result of transfer of NKCF from the effector cell to the target cell. The evidence presented here suggests that the IFN-induced augmentation of NK activity could be accounted for by an increase in the synthesis, activation, and/or release of NKCF.

Animals↗
PubMed1983

Studies on the mechanism of natural killer cell-mediated cytotoxicity. IV. Interferon-induced inhibition of NK target cell susceptibility to lysis is due to a defect in their ability to stimulate release of natural killer cytotoxic factors (NKCF).

The effects of interferon (IFN) at the level of the target cell in the natural killer cytotoxic factors (NKCF) system have been examined to determine whether they correlate with the effects of IFN in natural killer (NK) cell-mediated cytotoxicity (CMC). NKCF are released into the supernatant of co-cultures of murine spleen cells and YAC-1 stimulator cells, and their lytic activity is measured against YAC-1 target cells. It was found that IFN-pretreated YAC-1 target cells were still sensitive to lysis by NKCF, although their ability to stimulate release of NKCF from murine spleen cells was impaired. This defect was not due to a lack of NK target structures, because IFN-pretreated YAC-1 cells form a normal number of conjugates with spleen cells. The defect also could not be attributed to an IFN-induced inhibition of protein synthesis, because emetine-pretreated YAC-1 stimulator cells can still induce the release of high levels of NKCF. Cellfree supernatants containing NKCF also contain low levels of endogenous IFN (10 to 50 U/ml). Although this concentration of IFN itself is not toxic to YAC-1 cells, it may still interact with NKCF and/or the target cell to enhance cytotoxicity mediated by NKCF. Evidence in support of this possibility is derived from experiments that demonstrated that addition of exogenous IFN to NKCF resulted in a synergistic enhancement of cytotoxicity. Taken together, these findings can account for the IFN-induced inhibition of target cell susceptibility to lysis in the NK CMC system. In addition, the evidence supports our model for the role of NKCF in the mechanism of NK CMC. According to this model, the effector cell must first bind to the target cell; then the target cell delivers a signal to the effector cell to activate the NKCF release mechanism. The effector cell releases NKCF that then bind to the target cell and mediate cell lysis. The mechanism by which IFN-pretreated target cells become relatively NK-resistant appears to be a defect in their ability to stimulate the effector cell to release NKCF after the initial effector-target cell binding.

Animals↗
PubMed1983

Studies on the induction and expression of T cell-mediated immunity. XIV. Antigen-nonspecific oxidation-dependent cellular cytotoxicity (ODCC) mediated by sodium periodate oxidation of cytotoxic T lymphocytes.

Alloimmune murine thymus-derived cytotoxic lymphocytes (CTL) generated in vivo or in vitro are shown to lyse antigen-nonspecific target cells (tumor cells, Con A, and LPS blasts) following treatment of CTL with an oxidizing agent, sodium periodate (NaIO4). It has been shown that NaIO4 oxidizes terminal sialic acid residues of cell surface macromolecules. The presence of reactive aldehyde groups, generated by NaIO4 modification, is required for the expression of antigen-nonspecific cytotoxicity because treatment of modified cells with a reducing agent such as potassium borohydride (KBH4) resulted in the abrogation of cytotoxicity. However, KBH4 treatment of unmodified or NaIO4-modified CTL has no effect on antigen-specific cytotoxicity. The modification of CTL by NaIO4 is sufficient to lead to the formation of lymphocyte-target cell conjugates and lysis of bound targets. Monoclonal antibodies directed against the Lyt-2 antigens of CTL, but not Lyt-1 antigens, in the absence of complement inhibited the nonspecific cytotoxicity resulting from NaIO4 modification of effector lymphocytes. These findings suggest that the mere interaction with or perturbation of appropriate cell surface molecule(s) of effector lymphocytes such as Lyt antigens by receptor-ligand interaction in SCMC or by NaIO4 modification in ODCC may lead to the expression of cytotoxicity. The present studies demonstrate a functional role of surface carbohydrates on CTL in cell-to-cell recognition and interactions. Furthermore, the results suggest that target cell modification is not a requisite for recognition and lysis in an antigen-nonspecific cytotoxic system such as ODCC. However, partial blocking of ODCC by alloantibodies directed against the H-2 of unmodified target cells suggests that NaIO4-modified CTL recognize unrelated target H-2 antigens. The implication of these findings on the molecular mechanism of cell-mediated cytotoxicity is discussed.

Animals↗
PubMed1983

Serological demonstration of an allogeneic Ia.7 antigen on the cell surface of SJL/J-derived reticulum cell sarcomas.

The reticulum cell sarcomas (RCS) of SJL/J mice are of particular interest since they readily induce the proliferation of syngeneic T-lymphocytes. Previous cellular studies examined the antigens on the RCS which stimulated this response and suggested that the tumor expressed allogeneic I-region-associated (Ia) antigens normally associated with the E alpha:E beta molecular complex (S. M. Wilbur and B. J. Bonavida, Exp. Med., 153: 501-513, 1981). These particular Ia glycoproteins are not expressed on normal SJL/J cells due to a defect in the E alpha polypeptide synthetic pathway. However, the E beta subunit is synthesized normally by these animals but remains intracellular. The SJL/J-derived RCS may circumvent this defect in E alpha subunit biosynthesis. The aberrant synthesis of this polypeptide is thought to allow membrane presentation of an intact pseudoallogeneic Ia glycoprotein which utilized the normally dormant E beta s polypeptide. In the present study, two monoclonal antibodies directed against the Ia.7 specificity of the E alpha chain (13/18, 14-4-4S) were used to examine more directly the expression of this polypeptide on the tumor. Surprisingly, neither antibody was effective against the RCS in a direct complement-mediated cytolysis assay. Nevertheless, the tumor was found to specifically adsorb lytic activity of both the monoclonal antibodies. In addition, both a cold-cell competition assay and indirect immunofluorescence corroborated the data and indicated that the RCS does express detectable levels of the Ia.7 antigen. Normal spleen cells and lipopolysaccharide B-derived blasts from SJL/J mice were found in all experiments to be devoid of any specific reactivity with these monoclonal antibodies. In addition, continued in vivo passage of transplantable RCS was found to cause down-modulation of the Ia.7 specificities on these tumors. Newer RCS transplantable lines, however, expressed demonstrable levels of this alloantigen in both cellular and serological assays. The observed down-modulation could explain the difficulties encountered in defining this specificity on long-term transplantable RCS. In conclusion, the present serological study corroborates the early cell-binding data. An Ia.7 antigen is shown to be expressed on the RCS, yet this specificity could not be detected on normal SJL/J cells.

Animals↗
PubMed1983

Studies on the mechanism of natural killer cytotoxicity. II. coculture of human PBL with NK-sensitive or resistant cell lines stimulates release of natural killer cytotoxic factors (NKCF) selectively cytotoxic to NK-sensitive target cells.

This investigation has employed the "innocent bystander" type of experimental design to determine whether soluble cytotoxic factor(s) are released during interactions between human peripheral blood lymphocytes (PBL) and NK-sensitive target cells. PBL cocultured with NK-sensitive Molt-4 or K562 target cells in the lower well of a miniaturized Marbrook culture released natural killer cytotoxic factors (NKCF), which diffused across a 0.2-mu Nucleopore membrane and lysed Molt-4 or K562 target cells cultured in the upper chamber. Coculture of PBL with the NK-resistant Raji or WI-L2 cell lines also induced release of NKCF. These factors were selectively cytotoxic to NK-sensitive targets and lysed Molt-4 and, to a lesser extent, K562 cells. However, Raji, WI-L2, and RPMI 1788 cells were all resistant to lysis. In addition, low density fractions from Percoll density gradients that were enriched for NK effector cells also released increased levels of NKCF during coculture with Molt-4 cells. Lysis of Molt-4 and K562 targets was observed after exposure to NKCF for 48 hr and 60 to 70 hr, respectively. Cellfree supernatants containing NKCF were obtained after a short time of incubation (i.e., within 5 hr of coculture of PBL with NK target cells). The factors were nondialyzable, stable at 56 degrees C for 3 hr, and showed partial loss of activity on storage at 4 degrees C or -20 degrees C for 7 days. These data suggest that NKCF may be involved in the lytic mechanism of human NK cell-mediated cytotoxicity.

Cell Line↗
PubMed1982

Soluble cytotoxic factors and the mechanism of NK cell mediated cytotoxicity.

Soluble cytotoxic factors from mouse spleen cells have been shown to selectively lyse NK sensitive target cells. Lysis of target cells is assessed by trypan blue uptake or 51Cr--release assay in a 16-48 hour assay. The possible role of such natural killer cytotoxic factors (NKCF) in the mechanism of natural killer cell-mediated cytotoxicity (NKCMC) has been examined. Several lines of evidence are presented which indicate that there exists a strong correlation between lysis by NKCF and lysis in NKCMC. For instance, (1) NKCF are generated following stimulation of mouse spleen cells with NK sensitive targets; (2) Lysis of NKCF is selective for NK sensitive targets and is species specific; (3) Mice with poor NK activity, such as Bg/Bg mice, produce poor NKCF: (4) There is concomittant inhibition of NKCMC and NKCF activities by blocking RAT serum; and (5) Several known characteristics of the mechanism of NKCMC are shown to be shared in the NKCF system. Based on these findings, we propose a model for NKCMC in which lysis by NK effector cells is the result of multiple steps, namely target binding to an NK effector cell, activation of the lytic mechanism, and involvement of NKCF to mediate lysis. Accordingly, for targets to be NK sensitive, they ought to be able to interact and bind with NK effectors, activate the NK cells, bind NKCF, and be sensitive to the NKCF lytic activity.

Animals↗